October 7, 2010 — The US Food and Drug Administration (FDA) has approved clonidine hydrochloride, 0.1-mg and 0.2-mg, extended-release tablets (Kapvay; Shionogi Inc ...
MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company focused on attention deficit hyperactivity disorder (ADHD), pain, addiction and ...
FIGHTING FOR HER LIFE AFTER TAKING A DOSE. AND I’M NOT ASKING A WHOLE LOT OF QUESTIONS OTHER THAN WHEN SHE WAKING UP. WHEN DO I GET TO HOLD MY BABY? GET HER OUT OF THAT BED. BUT THERE ARE A LOT OF ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results